EUVIMEDEUVIMED entdecken
Crossref

Utility of a microRNA panel in diagnosis and prognosis of hepatitis C–associated hepatocellular carcinoma

Abeer Ahmed ALrefai iD, Sara Kamal Rizk iD, Ahmed Kamal Khamis iD, Zeinab A Kasemy iD, Mona Salah Eldin Habieb iD

Laboratory Medicine · 2024

DOI: 10.1093/labmed/lmad081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Laboratory Medicine, 2024. Verfasst von Abeer Ahmed ALrefai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biochemistry and Molecular Biology Department. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and the leading cause of cancer mortality. Various studies have linked dysregulated microRNA expression to liver cancers, but those related to viral hepatitis–related HCC are limited.

Methods

We investigated the diagnostic and prognostic roles of circulating miR-331-3p, miR-23b-3p, and miR-3194-5p in EDTA-treated blood samples of 50 hepatitis C virus (HCV) HCC patients, 50 HCV cirrhotic patients, and 50 healthy controls using quantitative real-time polymerase chain reaction.

Results

We found that miR-23b-3p and miR-3194-5p were significantly downregulated, whereas miR-331-3p was upregulated in HCC patients compared with controls. Also, these miRNAs were significantly dysregulated in HCC compared with cirrhotic patients. For the diagnosis of HCC, miR-331-3p and the combined miRNAs panel had the highest area under the curve (AUC), followed by miR-3194-5p. The highest AUC for differentiating metastatic from nonmetastatic patients was shown by miR-331-3p and the combined miRNAs panel, followed by miR-23b-3p. Dysregulation of miRNAs was associated with poor clinicopathological manifestations. Finally, miR-331-3P was found to be an independent risk factor for metastatic lesions in HCC.

Conclusion

Overall, the assessed miR-331-3p, miR-23b-3p, and miR-3194-5p were significantly associated with poor clinicopathological features of HCC and could be used to discriminate HCV-related HCC patients from cirrhosis and differentiating metastatic from nonmetastatic patients, primarily miR-331-3p along with combined miRNAs. Moreover, miR-331-3p was found to be an independent factor for metastatic lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsMicroRNAsHumansMaleFemaleMiddle AgedPrognosisHepatitis CAgedBiomarkers, TumorAdult

Stichwörter der Autor:innen

HCCHCVcirrhosismiRNAs

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Medical Biochemistry and Molecular Biology Department.
  • Biochemistry Department, Faculty of Medicine, UQU, Mecca, Kingdom of Saudi Arabia.
  • Internal Medicine Department, National Liver Institute.
  • Department of Public Health and Community Medicine, Faculty of Medicine, Menoufia University, Shibin El Kom, Egypt.
  • Medical Biochemistry Department, Najran University, Najran, Kingdom of Saudi Arabia.

ORCID-Profile: Abeer Ahmed ALrefai, Sara Kamal Rizk, Ahmed Kamal Khamis, Zeinab A Kasemy, Mona Salah Eldin Habieb

Zitieren

APA

ALrefai, A. A., Rizk, S. K., Khamis, A. K., Kasemy, Z. A., & Habieb, M. S. E. (2024). Utility of a microRNA panel in diagnosis and prognosis of hepatitis C–associated hepatocellular carcinoma. Laboratory Medicine. https://doi.org/10.1093/labmed/lmad081

Vancouver

ALrefai AA, Rizk SK, Khamis AK, Kasemy ZA, Habieb MSE. Utility of a microRNA panel in diagnosis and prognosis of hepatitis C–associated hepatocellular carcinoma. Laboratory Medicine. 2024. doi:10.1093/labmed/lmad081

BibTeX
@article{ALrefai2024,
  author = {ALrefai, Abeer Ahmed and Rizk, Sara Kamal and Khamis, Ahmed Kamal and Kasemy, Zeinab A and Habieb, Mona Salah Eldin},
  title = {Utility of a microRNA panel in diagnosis and prognosis of hepatitis C–associated hepatocellular carcinoma},
  journal = {Laboratory Medicine},
  year = {2024},
  doi = {10.1093/labmed/lmad081}
}
Kostenlos starten →